Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.37% | 145.20 | 0.7% | $948.12m | |
| PFE | Pfizer Inc. | -0.08% | 35.73 | 0.9% | $900.55m | |
| MRK | Merck & Co., Inc. | -0.66% | 82.60 | 0.7% | $692.09m | |
| ABBV | AbbVie, Inc. | 0.37% | 86.23 | 1.9% | $659.16m | |
| BMY | Bristol-Myers Squibb Co. | 1.67% | 59.22 | 1.0% | $624.16m | |
| LLY | Eli Lilly & Co. | 0.06% | 148.90 | 1.1% | $561.38m | |
| AZN | AstraZeneca Plc | 0.07% | 54.21 | 1.2% | $245.83m | |
| NVS | Novartis AG | 0.28% | 86.54 | 0.2% | $164.20m | |
| GSK | GlaxoSmithKline Plc | 0.56% | 37.59 | 0.2% | $105.60m | |
| PRNB | Principia Biopharma, Inc. | 0.01% | 99.96 | 0.0% | $80.21m | |
| NVO | Novo Nordisk A/S | 0.40% | 68.54 | 0.1% | $57.25m | |
| SNY | Sanofi | -1.08% | 50.24 | 0.2% | $48.80m | |
| RGEN | Repligen Corp. | 0.48% | 140.61 | 7.1% | $47.76m | |
| RPRX | Royalty Pharma Plc | 1.32% | 40.76 | 0.2% | $47.25m | |
| OPK | OPKO Health, Inc. | 1.14% | 3.11 | 11.2% | $44.20m |
Company Profile
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.